Division of Cardiovascular Medicine Archives
Jan. 14, 2021—Following a Thanksgiving surge that led to record numbers of admissions of patients with COVID-19, residents and fellows from multiple disciplines have come together under the direction and supervision of critical care attendings to provide the best care to critically ill patients in Vanderbilt University Medical Center’s COVID-19 Intensive Care Unit.
Jan. 7, 2021—Jane Freedman, MD, will join Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute, effective Aug. 1.
Jan. 6, 2021—Researchers from the Broad Institute of Harvard and MIT, the National Institutes of Health (NIH) and Vanderbilt University Medical Center for the first time have used a novel genome-editing technique to “rescue” mice from progeria, a rare genetic disease that causes accelerated aging.
Sep. 10, 2020—Sourav Panja, PhD, a postdoctoral scholar in the Department of Pediatrics at Vanderbilt University Medical Center, was working in his lab one evening last year when he began coughing up blood. Even breathing was becoming difficult.
Feb. 27, 2020—A Polygenic Risk Score — a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients — has been found not to be a useful predictive biomarker for disease risk.
Jan. 9, 2020—Dan Roden, MD, and Daniel Munoz, have been named interim directors of the Division of Cardiovascular Medicine at Vanderbilt University Medical Center.
Oct. 24, 2019—Thomas Wang, MD, director of Cardiovascular Medicine at VUMC, has been appointed chair of Internal Medicine at the University of Texas Southwestern Medical Center in Dallas, effective February 2020.